Keppra-PSUSA-00001846-202411 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
scientific-conclusion
medication.label.permit_number
EMADOC-1700519818-2544162
medication.label.permit_validity
First published: 2025-10-20T13:27:38Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live